Views & Analysis The Simulated Cell: can a digital model aid cancer drug disc... Can a simulated cell hold the key to sky-high attrition rates between cancer drug discovery and approval?
News UK drug discovery evolving - and facing up to Brexit A new UK report confirms the shift in pharma R&D spending from in-house teams to greater use of outsourcing and in-licensing - but also warns that investment in drug discovery in the co
News Stanford and twoXAR strike deal to take on liver cancer Stanford University School of Medicine is to take on liver cancer by teaming with twoXAR to develop new drug candidates.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.